| Which randomized controlled trial do we need ? Routine replacement versus clinically indicated replacement for peripheral venous catheters for reducing bloodstream infections : a cluster-randomized controlled trial | Clinical microbiology and infection |  | | 2026 | 13 | 0 |
|
| Randomized Clinical Trials Using a Hierarchical Composite Primary End Point : A Scoping Review | JAMA network open |  | | 2026 | 9 | 47 |
|
| Response to Matters Arising about the etiology of ventilator-associated pneumonia in the European POS-VAP cohort | Critical care | | | 2026 | 7 | 15 |
|
| Perpetual observational study of the clinical and microbiological epidemiology of ventilator-associated pneumonia in Europe | Critical care | | | 2026 | 16 | 121 |
|
| A comparison of frequentist and Bayesian approaches to the Personalised Randomised Controlled Trial (PRACTical)-design and analysis considerations | BMC Medical research methodology | | | 2025 | 42 | 78 |
|
| β-Lactam vs Non-β-Lactam Antimicrobial Prophylaxis and Surgical Site Infection | JAMA network open | | | 2025 | 18 | 193 |
|
| Dwell Time and Risk of Bloodstream Infection With Peripheral Intravenous Catheters | JAMA network open | | | 2025 | 54 | 250 |
|
| Secular trends of bloodstream infections in hemodialysis patients : insights from a longitudinal Swiss study | Antimicrobial resistance and infection control | | | 2025 | 41 | 157 |
|
| Sustained effect of a multifaceted VAP prevention program over more than seven years including the COVID-19 pandemic | Antimicrobial resistance and infection control | | | 2025 | 20 | 101 |
|
| Benefits of group sequential design and sample size re-estimation for randomised controlled trials evaluating the prevention of ventilator-associated pneumonia : a simulation study informed by real world data | BMC Medical research methodology | | | 2025 | 18 | 199 |
|
| In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza : a retrospective, nationwide cohort study in Switzerland | Clinical infectious diseases | | | 2024 | 77 | 245 |
|
| Identifying prodromal symptoms at high specificity for Parkinson's disease | Frontiers in aging neuroscience | | | 2023 | 79 | 349 |
|
| Using biomarkers to allocate patients in a response-adaptive clinical trial | Communications in statistics. Simulation and computation | | | 2023 | 62 | 180 |
|
| An Alternative to Traditional Sample Size Determination for Small Patient Populations | Statistics in biopharmaceutical research | | | 2022 | 100 | 53 |
|
| Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression | Frontiers in neuroscience | | | 2021 | 123 | 250 |
|
| Patterns of routine primary care for osteoarthritis in the UK : a cross-sectional electronic health records study | BMJ open | | | 2017 | 39 | 26 |
|
